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Abstract The Covid-19 pandemic has intensified interest in animals with superior 
antiviral defences. I argue that the role of such animals in biomedical research con-
trasts with the role of disease models.
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Much biomedical research uses animal models to investigate human diseases. The 
Covid-19 pandemic shines a spotlight on a very different, and perplexing, way of 
employing animals in biomedical research: as medical toolkits rather than as mod-
els. This note sketches (what I will call) the toolkit strategy for using animals in 
biomedical research.
As the examples below will show, some animals evolved antidisease strategies 
that are superior to those of humans. Consequently, some biomedical researchers 
aim to uncover the underpinning mechanisms and to determine whether the animals’ 
strategies can be reproduced in humans. In this context, animals are employed like 
medical toolkits, i.e. collections of ready-to-use equipment and supplies for treat-
ing medical conditions. In contrast to disease models, toolkit organisms are investi-
gated despite and because of the fact that their features are expected to be absent in 
humans.
This note belongs to the Topical Collection “Seeing Clearly Through COVID-19: Current and future 
questions for the history and philosophy of the life sciences”, edited by G. Boniolo and L. Onaga.
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Humans and many other mammals defend themselves against viruses by activat-
ing the innate immune response (in the first instance). Receptors sense the presence 
of viral material in the body and trigger pathways that prompt antiviral defences 
like inflammation. Bats and pangolins are known to cope much better than humans 
with many viruses, including SARS-Cov-2. As it turns out, they dampen rather than 
boost their innate immune response. They have permanently inactivated the genes 
for virus-sensing receptors such as IFIH1 and ZBP1 (Fischer et al. 2020a) and AIM2 
(Gorbunova et al. 2020). Furthermore, pangolins have eliminated the cGAS-STING 
signalling pathway, which receptors trigger when detecting viral material (Fischer 
et  al. 2020b). Bats reduce the inflammation response to TNF-signaling (Gorbu-
nova et al. 2020). Such findings raise the possibility of reproducing these strategies 
in humans. It may be possible, for instance, to pharmaceutically suppress IFIH1-
dependent signaling (Fischer et al. 2020a).
Relatedly, naked mole rats evolved highly effective anticancer strategies (Selu-
anov et al. 2018). Their cells, for example, quickly cease to proliferate when encoun-
tering other cells. Early contact inhibition is due to unusually long versions of hya-
luronic acid (HA), which is the main non-protein component in the extracellular 
matrix. Early contact inhibition may be replicated in humans by lengthening HA 
(Seluanov et al. 2018). Interestingly, Seluanov and Gorbunova found “a very prom-
ising molecule that increases the amount and most importantly the size of HA” in 
human cell cultures (pers. comm. 5/10/2020).
In the examples above, researchers investigate bats, pangolins, and naked mole 
rats despite knowing that humans lack their antiviral and anticancer strategies. In 
fact, researchers  investigate these organisms  because they know this. It would be 
pointless to probe the strategies’ reproducibility if they already operated in humans. 
Furthermore, given that the animals’ strategies are expected to be absent in humans, 
extrapolating the underpinning mechanisms would be unjustified. Thus, employing 
animals as toolkits for human diseases is not only different from, but contrary to, 
using them as disease models. Note, however, that the same organism may serve as a 
toolkit in one context and as a disease model in another.
Green et al. (2018) may be the first HPS discussion of biomedical research into 
organisms with adaptations that are absent but desirable in humans. The authors 
construe such organisms as “negative models”, since humans lack their adaptations. 
They also explore whether it is “possible to generalize or translate” the insights 
gained, and conclude that the adaptations of some, but not all, such organisms are 
“applicable or generalizable across species”. Green et  al. (2018) glide seamlessly 
from applicability and translatability to generalizability and therefore miss a key fea-
ture of toolkit organisms: whereas the adaptations of these organisms may be appli-
cable or translatable (by introducing or replicating the adaptations in humans), they 
are not generalisable (because inferences like “since pangolins have mechanism M, 
so do humans” are unwarranted). Put differently, the adaptations may be generalis-
able in a practical, but never in an epistemic, sense. Toolkit organisms really are 
distinct from disease models.
Employing animals as medical toolkits is also different from using them as instru-
ments or measuring devices (Germain 2014). When animals serve as instruments, 
the presence/absence of a state in the animal (e.g. follicular blood spots) indicates 
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the presence/absence of a different state in humans (e.g. pregnancy). This is still an 
animal-to-human inference, albeit not a generalisation. Yet even such non-generalis-
ing inferences are unnecessary and unjustified when animals serve as toolkits.
Note that replicating an organism’s solution in humans need not require repli-
cating the organism’s mechanism(s) for that solution. Pangolins dampen the innate 
immune response against RNA viruses (solution) by inactivating receptor genes 
(mechanism). In humans, however, inhibiting receptor activity pharmaceutically 
may achieve the same result. Furthermore, whatever the (dis)similarities between an 
animal’s mechanism and the one introduced in humans, the latter mechanism may 
be more or less similar to existing processes in humans. For instance, inhibiting the 
activity of our receptors would diverge less from our biology than permanently inac-
tivating our receptor genes.
Finally, it is natural to make the uniqueness of the adaptations of toolkit organ-
isms responsible for the failure of extrapolation. But this would be a mistake. Among 
healthy vertebrates, low-density bones and lack of haemoglobin are unique to Ant-
arctic icefish. But these features are similar to pathological conditions in human 
anaemias and osteoporosis. Identifying the associated genes in icefish licences infer-
ences about the mutations implicated in human pathologies. Hence, despite their 
unique adaptations, icefish serve as (“evolutionary mutant”) models for human dis-
eases (Albertson et al. 2009).
This note offered a sketch of biomedical research that employs animals as tool-
kits. The history of the toolkit strategy, its relation to modelling, and its potential for 
addressing Covid-19 are future questions for HPS.
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